Tyrosine kinase inhibitors modulate the apoptomirs: MIR-16, MIR-21, MIR-30E, MIR-145, MIR-142-3P, MIR-LET-7D, MIR-LET-7E and MIR-15A expression in BCR-ABL-positive cell (2011)
- Authors:
- USP affiliated authors: COVAS, DIMAS TADEU - FMRP ; SIMOES, BELINDA PINTO - FMRP ; CASTRO, FABÍOLA ATTIÉ DE - FCFRP ; SOUZA, ANA MARIA DE - FCFRP ; SILVA JUNIOR, WILSON ARAÚJO DA - FMRP
- Unidades: FMRP; FCFRP
- Subjects: EXPRESSÃO GÊNICA; APOPTOSE; ONCOGENES; LEUCEMIA MIELÓIDE
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Haematologica
- ISSN: 0390-6078
- Volume/Número/Paginação/Ano: v. 96, suppl. 2, p. 597-598, res. 1512, 2011
- Conference titles: Congress of The European Hematology Association
-
ABNT
FERREIRA, A. et al. Tyrosine kinase inhibitors modulate the apoptomirs: MIR-16, MIR-21, MIR-30E, MIR-145, MIR-142-3P, MIR-LET-7D, MIR-LET-7E and MIR-15A expression in BCR-ABL-positive cell. Haematologica. Pavia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 16 abr. 2024. , 2011 -
APA
Ferreira, A., Moura, L., Simoes, B. P., Silva Júnior, W. A. da, Kashima, S., Covas, D. T., et al. (2011). Tyrosine kinase inhibitors modulate the apoptomirs: MIR-16, MIR-21, MIR-30E, MIR-145, MIR-142-3P, MIR-LET-7D, MIR-LET-7E and MIR-15A expression in BCR-ABL-positive cell. Haematologica. Pavia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. -
NLM
Ferreira A, Moura L, Simoes BP, Silva Júnior WA da, Kashima S, Covas DT, Souza AM de, Castro FA de. Tyrosine kinase inhibitors modulate the apoptomirs: MIR-16, MIR-21, MIR-30E, MIR-145, MIR-142-3P, MIR-LET-7D, MIR-LET-7E and MIR-15A expression in BCR-ABL-positive cell. Haematologica. 2011 ; 96 597-598.[citado 2024 abr. 16 ] -
Vancouver
Ferreira A, Moura L, Simoes BP, Silva Júnior WA da, Kashima S, Covas DT, Souza AM de, Castro FA de. Tyrosine kinase inhibitors modulate the apoptomirs: MIR-16, MIR-21, MIR-30E, MIR-145, MIR-142-3P, MIR-LET-7D, MIR-LET-7E and MIR-15A expression in BCR-ABL-positive cell. Haematologica. 2011 ; 96 597-598.[citado 2024 abr. 16 ] - Differential expression of the flice-inhibitory protein, C-flip, in 'CD34 POT.+'cells in chronic myelogenous leukemia, polycythemia vera and essential trombocythemia
- miR-142-3p expression is associated with imatinib resistance and c-flip anti-apoptotic gene expression in chronic myeloid leukemia patients
- PRV-1 overexpression in essential thrombocythemia correlates with trail expression
- Apoptomirs expression profile in polycythemia vera patients
- Differential expression of apopttomiRs in myeloproliferative neoplasms. [Carta]
- Deregulation of apoptosis-related genes is associated with PRV1 overexpression and JAK2 V617F allele burden in essential thrombocythemia and myelofibrosis
- Deregulated expression of A1, Bcl-2, Bcl-xL, and Mcl-1 antiapoptotic proteins and Bid, Bad, and Bax proapoptotic genes in polycythemia vera patients
- Apoptosis-related gene expression profile in chronic myeloid leukemia patients after imatinib mesylate and dasatinib therapy
- ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance
- Differential expression of the flice-inhibitory protein, c-flip, in cd34+ cells myelogenous leukemia, polycythemia vera and essential thombocythemia
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
